Skip to content
The Policy VaultThe Policy Vault

Xtampza ERCareFirst (Caremark)

Pain associated with cancer

Approval duration

12 months for pain associated with cancer, sickle cell disease, terminal condition, or hospice/palliative care; 6 months for chronic pain